NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries

Hypertension

Volumn 41, Issue 6, 2003, Pages 1301-1307

  Irvine, Jennifer C ^b   Favaloro, Joanne L ^b   Kemp Harper, Barbara K ^a  

^a MONASH UNIVERSITY   (Australia)

^b NONE

Author keywords

Mesenteric arteries; Nitric oxide; Nitroxyl anion; Potassium channels; Vasculature; Vasorelaxation

Indexed keywords

APAMIN; CHARYBDOTOXIN; GLIBENCLAMIDE; GUANYLATE CYCLASE; IBERIOTOXIN; NITRIC OXIDE; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; MALE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; MICROVASCULATURE; MYOGRAPHY; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT; RESISTANCE BLOOD VESSEL; SMOOTH MUSCLE RELAXATION; VASCULAR RESISTANCE; VASODILATATION;

ANIMALS; ARTERIES; BENZOATES; CULTURE TECHNIQUES; CYSTEINE; ENZYME ACTIVATION; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; GUANYLATE CYCLASE; IMIDAZOLES; MALE; NITRIC OXIDE DONORS; NITRITES; NITROGEN OXIDES; NITROPRUSSIDE; OXADIAZOLES; POTASSIUM; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, VOLTAGE-GATED; QUINOXALINES; RATS; RATS, INBRED WKY; VASCULAR RESISTANCE; VASODILATION;

EID: 0038796529     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000072010.54901.DE     Document Type: Article

References (37)

1. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-140.
2. Hobbs AJ, Fukuto JM, Ignarro LJ. Formation of free nitric oxide from L-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase. Proc Natl Acad Sci U S A. 1994;91:10992-10996.
3. • from NO synthase. Proc Natl Acad Sci U S A. 1996;93:14492-14497.
4. Ellis A, Li CG, Rand MJ. Differential actions of L-cysteine on responses to nitric oxide, nitroxyl anions and EDRF in the rat aorta. Br J Pharmacol. 2000;129:315-322.
5. Wanstall JC, Jeffery TK, Gambino A, Lovren F, Triggle CR. Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion. Br J Pharmacol. 2001;134:463-472.
6. Fukuto JM, Wallace GC, Hszieh R, Chaudhuri G. Chemical oxidation of N-hydroxyguanidine compounds: release of nitric oxide, nitroxyl and possible relationship to the mechanism of biological nitric oxide generation. Biochem Pharmacol. 1992;43:607-613.
7. G-hydroxyl-L-arginine by nitric oxide synthase. Biochemistry. 1995;34:1930-1941.
8. Adak S, Wang Q, Stuehr DJ. Arginine conversion of nitroxide by tetrahydrobiopterin-free neuronal nitric-oxide synthase. J Biol Chem. 2000;275:33554-33561.
9. - donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch Biochem Biophys. 1995;318:279-285.
10. Wong PSY, Hyun J, Fukuto JM, Shirota FN, DeMaster EG, Shoeman DW, Nagasawa HT. Reaction between S-nitrosothiols and thiols: generation of nitroxyl (HNO) and subsequent chemistry. Biochemistry. 1998;37:5362-5371.
11. -) and singlet oxygen in aqueous solutions. PNAS. 2000;97:2984-2989.
12. Sharpe MA, Cooper CE. Reactions of nitric oxide with mitochondrial cytochrome c: a novel mechanism for the formation of nitroxyl anion and peroxynitrite. Biochem J. 1998;332:9-19.
13. Fukuto JM, Chiang K, Hszieh R, Wong PSY, Chaudhurri G. The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor. J Pharmacol Exp Ther. 1992;263:546-551.
14. De Witt BJ, Marrone JR, Kaye AD, Keefer LK, Kadowitz PJ. Comparison of responses to novel nitric oxide donors in the feline pulmonary vascular bed. Eur J Pharmacol. 2001;430:311-315.
15. Ma XL, Gao F, Liu G-L, Lopez BL, Christopher TA, Fukuto JM, Wink DA, Feelisch M. Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury. Proc Natl Acad Sci U S A. 1999;96:14617-14622.
16. Kemp BK, Cocks TM. Evidence that mechanisms dependent and independent of nitric oxide mediate endothelium-dependent relaxation to bradykinin in human small resistance-like coronary arteries. Br J Pharmacol. 1997;120:757-762.
17. McPherson GA. Optimal conditions for assessing vascular reactivity in small resistance arteries in the small vessel myograph. Clin Exp Pharmacol Physiol. 1992;19:815-825.
18. Murphy ME, Sies H. Reversible conversion of nitroxyl anion to nitric oxide by superoxide dismutase. Proc Natl Acad Sci U S A. 1991;88:10860-10864.
19. Nelli S, Hillen M, Buyukafsar K, Martin W. Oxidation of nitroxyl anion to nitric oxide by copper ions. Br J Pharmacol. 2000;131:356-362.
20. • released from the nitroxyl anion donor Angeli's salt. Br J Pharmacol. 2001;134:521-528.
21. •), the only nitrogen monoxide redox form capable of activating soluble guanylyl cyclase. Biochem Pharmacol. 1996;51:1593-1600.
22. 450 in the vasodilator actions of the nitroxyl anion generator, Angeli's salt, on rat aorta. Eur J Pharmacol. 2001;412:281-289.
23. Li CG, Karagiannis J, Rand MJ. Comparison of the redox forms of nitrogen monoxide with the nitrergic transmitter in the rat anococcygeus muscle. Br J Pharmacol. 1999;127:826-834.
24. -) using L-cysteine. Biochem Biophys Res Commun. 1994;201:54-62.
25. Costa G, Labadia A, Triguero D, Jimenez E, Garcia-Pascual A. Nitrergic relaxation in urethral smooth muscle: involvement of potassium channels and alternative redox forms of NO. Naunyn Schmiedebergs Arch Pharmacol. 2001;364:516-523.
26. Fukuto JM, Hobbs AJ, Ignarro LJ. Conversion of nitroxyl (HNO) to nitric oxide (NO) in biological systems: the role of physiological oxidants and relevance to the biological activity of HNO. Biochem Biophys Res Commun. 1993;196:707-713.
27. Buyukafsar K, Nelli S, Martin W. Formation of nitric oxide from nitroxyl anion: role of quinones and ferricytochrome c. Br J Pharmacol. 2001;132:165-172.
28. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxodiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol. 1995;48:184-188.
29. Onoue H, Katusic ZS. The effect of 1H-[1,2,4]oxodiazolo[4,3a]quinoxalin-1-one (ODQ) and charybdotoxin on relaxations of isolated cerebral arteries to nitric oxide. Brain Res. 1998;785:107-113.
30. + channel genes in mesenteric artery smooth muscle cells. Am J Physiol. 1999;277:G1055-G1063.
31. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 1994;368:850-853.
32. Ca) in smooth muscle cells isolated from the rat mesenteric artery. Br J Pharmacol. 1998;124:1131-1140.
33. Plane F, Sampson LJ, Smith JJ, Garland CJ. Relaxation to authentic nitric oxide and SIN-1 in rat isolated mesenteric arteries: variable role for smooth muscle hyperpolarization. Br J Pharmacol. 2001;133:665-672.
34. Ca channels antagonizes NO-induced relaxation in pulmonary artery. Am J Physiol. 1997;272:H904-H912.
35. Lovren F, Triggle CR. Nitric oxide and sodium nitroprusside-induced relaxation of the human umbilical artery. Br J Pharmacol. 2000;131:521-536.
36. + channels in cerebral artery smooth muscle cells. Am J Physiol. 1993;265:C299-C303.
37. Onoue H, Katusic ZS. Subarachnoid hemorrhage and the role of potassium channels in relaxations of canine basilar artery to nitrovasodilators. J Cereb Blood Flow Metab. 1998;18:186-195.